These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1491965)

  • 1. [A clinical evaluation of MAb BW 835/6 in breast and ovarian cancer].
    Trampert L; Villena C; Benz P; Keweloh HC; Schmidt W; Oberhausen E
    Nuklearmedizin; 1992 Dec; 31(6):249-53. PubMed ID: 1491965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radioimmunoimaging assay of ovarian tumor with 99mTc labeled anti-carcinoembryonic antigen monoclonal antibody].
    Wu LY; Wu AR; Zhan J
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jun; 29(6):340-2, 381-2. PubMed ID: 8001407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunodetection in cancer identification.
    Goldenberg DM; Larson SM
    J Nucl Med; 1992 May; 33(5):803-14. PubMed ID: 1569493
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer.
    Granowska M; Britton KE; Mather SJ; Lowe DG; Ellison D; Bomanji J; Burchell J; Taylor-Papadimitriou J; Hudson CR; Shepherd JH
    Eur J Nucl Med; 1993 Jun; 20(6):483-9. PubMed ID: 8339731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences.
    Alexander C; Villena-Heinsen CE; Trampert L; Lung-Kurt S; Oberhausen E; Kirsch CM; Schmidt W
    Eur J Nucl Med; 1995 Jul; 22(7):645-51. PubMed ID: 7498226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody.
    Chung JK; Kang SB; Lee HP; Lee MC; Koh CS; Sakahara H; Endo K
    J Nucl Med; 1993 Oct; 34(10):1651-5. PubMed ID: 8410277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW 431/26) reacting with carcinoembryonic antigen in breast cancer.
    Kairemo KJ
    Cancer Res; 1990 Feb; 50(3 Suppl):949s-954s. PubMed ID: 2297747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody targeting of ovarian carcinoma.
    Kosmas C; Kalofonos HP; Hird V; Epenetos AA
    Oncology; 1998; 55(5):435-46. PubMed ID: 9732222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II study.
    McQuarrie SA; MacLean GD; Boniface GR; Golberg K; McEwan AJ
    Eur J Nucl Med; 1997 Apr; 24(4):381-9. PubMed ID: 9096088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of radioimmunodetection with a radiolabeled monoclonal antibody to CEA (BW 431/26) in colorectal and breast cancer.
    Lind P
    Pathol Biol (Paris); 1993 Jan; 41(1):39. PubMed ID: 8316463
    [No Abstract]   [Full Text] [Related]  

  • 11. Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer.
    Rubin SC; Kostakoglu L; Divgi C; Federici MG; Finstad CL; Lloyd KO; Larson SM; Hoskins WJ
    Gynecol Oncol; 1993 Oct; 51(1):61-6. PubMed ID: 8244176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoscintigraphy of gynecologic tumors with 131I-labeled anti-PLAP monoclonal antibodies.
    Riklund KE; Edbom G; Makiya R; Johansson B; Gerdes U; Hietala SO; Ekelund L; Stigbrand T; Stendahl U
    Acta Radiol; 1991 Sep; 32(5):375-80. PubMed ID: 1910991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian mass, bone metastases, and a breast lesion.
    Bassett LW
    AJR Am J Roentgenol; 1978 Jun; 130(6):1163-4. PubMed ID: 418659
    [No Abstract]   [Full Text] [Related]  

  • 14. The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
    Dean CJ; Allan S; Eccles S; McFarlane C; Styles J; Valeri M; Sandle J; Bakir A; Sacks N
    Year Immunol; 1993; 7():182-92. PubMed ID: 8103950
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
    Malamitsi J; Skarlos D; Fotiou S; Papakostas P; Aravantinos G; Vassilarou D; Taylor-Papadimitriou J; Koutoulidis K; Hooker G; Snook D
    J Nucl Med; 1988 Dec; 29(12):1910-5. PubMed ID: 3193206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of immunoscintigraphy in managing ovarian cancer.
    Krag DN
    J Nucl Med; 1993 Mar; 34(3 Suppl):545-8. PubMed ID: 8441055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunolocalization of human malignant tumors with In-111 labeled monoclonal antibody.
    Han B; Liu CG; Fang YX; Yuan M; Jiang YY; Tian JH; Wu CC; Wu YH; Liu YF
    Chin Med J (Engl); 1991 Dec; 104(12):999-1004. PubMed ID: 1782819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies.
    Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Corstens FH
    Eur J Obstet Gynecol Reprod Biol; 1991 Aug; 41(1):47-63. PubMed ID: 1748227
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tumor immunity in patients with ovarian cancer after immunoscintigraphy in a long-term follow-up.
    Donnerstag B; Baum RP; Oltrogge JB; Henzel K; Träger L; Hör G
    Hybridoma; 1995 Apr; 14(2):191-7. PubMed ID: 7590779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.